193 related articles for article (PubMed ID: 27394707)
1. Cabergoline treatment for recurrent Cushing's disease during pregnancy.
Nakhleh A; Saiegh L; Reut M; Ahmad MS; Pearl IW; Shechner C
Hormones (Athens); 2016 Jul; 15(3):453-458. PubMed ID: 27394707
[TBL] [Abstract][Full Text] [Related]
2. Use of cabergoline for the management of persistent Cushing's disease in pregnancy.
Sek KS; Deepak DS; Lee KO
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710189
[TBL] [Abstract][Full Text] [Related]
3. Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma.
Miyoshi T; Otsuka F; Takeda M; Inagaki K; Suzuki J; Ogura T; Date I; Hashimoto K; Makino H
J Endocrinol Invest; 2004 Dec; 27(11):1055-9. PubMed ID: 15754738
[TBL] [Abstract][Full Text] [Related]
4. Macrocorticotropinoma shrinkage and control of hypercortisolism under long-term cabergoline therapy: case report.
Manavela MP; Danilowicz K; Bruno OD
Pituitary; 2012 Dec; 15 Suppl 1():33-6. PubMed ID: 22038028
[TBL] [Abstract][Full Text] [Related]
5. Cabergoline therapy for Cushing disease throughout pregnancy.
Woo I; Ehsanipoor RM
Obstet Gynecol; 2013 Aug; 122(2 Pt 2):485-487. PubMed ID: 23884269
[TBL] [Abstract][Full Text] [Related]
6. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
[TBL] [Abstract][Full Text] [Related]
7. [Use of cabergoline in persisting Cushing's disease].
Illouz F; Dubois-Ginouves S; Laboureau S; Rohmer V; Rodien P
Ann Endocrinol (Paris); 2006 Sep; 67(4):353-6. PubMed ID: 17072242
[TBL] [Abstract][Full Text] [Related]
8. How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild?
Ragonese M; Cotta OR; Ferraù F; Trimarchi F; Cannavò S
Gynecol Endocrinol; 2012 Aug; 28(8):637-9. PubMed ID: 22309603
[TBL] [Abstract][Full Text] [Related]
9. Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
Burman P; Edén-Engström B; Ekman B; Karlsson FA; Schwarcz E; Wahlberg J
Eur J Endocrinol; 2016 Jan; 174(1):17-24. PubMed ID: 26582653
[TBL] [Abstract][Full Text] [Related]
10. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
11. Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation.
Boronat M; Marrero D; López-Plasencia Y; Barber M; Schamann Y; Nóvoa FJ
Gynecol Endocrinol; 2011 Sep; 27(9):675-7. PubMed ID: 20923280
[TBL] [Abstract][Full Text] [Related]
12. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
[TBL] [Abstract][Full Text] [Related]
13. Remission with cabergoline in adolescent boys with Cushing's disease.
Güven A; Baltacıoğlu F; Dursun F; Cebeci AN; Kırmızıbekmez H
J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):194-8. PubMed ID: 24072089
[TBL] [Abstract][Full Text] [Related]
14. Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.
Hána V; Dokoupilová M; Marek J; Plavka R
Clin Endocrinol (Oxf); 2001 Feb; 54(2):277-81. PubMed ID: 11207645
[TBL] [Abstract][Full Text] [Related]
15. Cushing's disease and pregnancy: case report and literature review.
Yawar A; Zuberi LM; Haque N
Endocr Pract; 2007; 13(3):296-9. PubMed ID: 17599863
[TBL] [Abstract][Full Text] [Related]
16. Cabergoline for Cushing's disease: a large retrospective multicenter study.
Ferriere A; Cortet C; Chanson P; Delemer B; Caron P; Chabre O; Reznik Y; Bertherat J; Rohmer V; Briet C; Raingeard I; Castinetti F; Beckers A; Vroonen L; Maiter D; Cephise-Velayoudom FL; Nunes ML; Haissaguerre M; Tabarin A
Eur J Endocrinol; 2017 Mar; 176(3):305-314. PubMed ID: 28007845
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.
Johnston PC; Kennedy L; Hamrahian AH; Sandouk Z; Bena J; Hatipoglu B; Weil RJ
Pituitary; 2017 Aug; 20(4):430-440. PubMed ID: 28265841
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Viecceli C; Mattos ACV; Costa MCB; de Melo RB; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2022; 13():1017331. PubMed ID: 36277689
[TBL] [Abstract][Full Text] [Related]
19. The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery.
Pivonello R; De Martino MC; Cappabianca P; De Leo M; Faggiano A; Lombardi G; Hofland LJ; Lamberts SW; Colao A
J Clin Endocrinol Metab; 2009 Jan; 94(1):223-30. PubMed ID: 18957500
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
